AI-generated summary
The authors randomized 104 patients with treatment-failure or drug-resistant tubercular lymphadenopathy, sinuses or cold abscess to nitrogen laser plus antitubercular drugs or drugs with sham laser. The laser group reported higher bacteriological conversion at five weeks and a larger reduction in gland size, and faster sinus closure, and the authors suggest it may be an adjunct therapy.
- Participants
- 104
- Who or what was studied
- Patients with treatment-failure or drug-resistant tubercular lymphadenopathy, sinuses or cold abscess
- Wavelengths
- 337 nm
- Limits stated in the abstract
- The abstract does not describe the study's sample size justification or certainty of the findings, and the conclusion is stated in tentative terms.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 5 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Randomized controlled trial, Primary outcome, Control group, Power output, Nanometer, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.